Enanta Pharmaceuticals Stock Price on October 23, 2024
| ENTA Stock | USD 8.60 0.23 2.60% |
Below is the normalized historical share price chart for Enanta Pharmaceuticals extending back to March 21, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Enanta Pharmaceuticals stands at 8.60, as last reported on the 30th of November, with the highest price reaching 9.11 and the lowest price hitting 8.52 during the day.
If you're considering investing in Enanta Stock, it is important to understand the factors that can impact its price. Enanta Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.21, which denotes the company had a -0.21% return per unit of standard deviation over the last 3 months. Enanta Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Enanta Pharmaceuticals' Coefficient Of Variation of (438.98), mean deviation of 2.15, and Standard Deviation of 2.62 to check the risk estimate we provide.
The current year's Stock Based Compensation To Revenue is expected to grow to 0.42, whereas Common Stock Shares Outstanding is forecasted to decline to about 18.4 M. . At present, Enanta Pharmaceuticals' Price To Sales Ratio is projected to slightly decrease based on the last few years of reporting. The current year's Price Book Value Ratio is expected to grow to 1.88, whereas Price Earnings Ratio is projected to grow to (1.79). Enanta Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 21st of March 2013 | 200 Day MA 12.9755 | 50 Day MA 10.9155 | Beta 0.568 |
Enanta |
Sharpe Ratio = -0.2135
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ENTA |
Estimated Market Risk
| 2.68 actual daily | 23 77% of assets are more volatile |
Expected Return
| -0.57 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.21 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Enanta Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Enanta Pharmaceuticals by adding Enanta Pharmaceuticals to a well-diversified portfolio.
Price Book 1.4528 | Enterprise Value Ebitda (0.29) | Price Sales 2.5329 | Shares Float 15.4 M | Wall Street Target Price 18.125 |
Related Headline
Inhibrx Headline on 23rd of October 2024
Disposition of 15000 shares by Kayyem Jon Faiz of Inhibrx at... by Kayyem Jon Faiz
Filed transaction by Inhibrx Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Enanta Pharmaceuticals Valuation on October 23, 2024
It is possible to determine the worth of Enanta Pharmaceuticals on a given historical date. On October 23, 2024 Enanta was worth 12.96 at the beginning of the trading date compared to the closed value of 12.75. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Enanta Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Enanta Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Enanta Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Enanta Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 12.58 | 13.13 | 12.47 | 13.00 | 136,913 | |
10/23/2024 | 12.96 | 13.37 | 12.25 | 12.75 | 210,415 |
| 12.73 | 12.81 | 12.09 | 12.15 | 147,315 |
| Backtest Enanta Pharmaceuticals | | | Enanta Pharmaceuticals History | | | Enanta Pharmaceuticals Valuation | Previous | Next |
Enanta Pharmaceuticals Trading Date Momentum on October 23, 2024
| On October 24 2024 Enanta Pharmaceuticals was traded for 12.15 at the closing time. The top price for the day was 12.81 and the lowest listed price was 12.09 . The trading volume for the day was 147.3 K. The trading history from October 24, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 4.71% . The overall trading delta against the current closing price is 14.35% . |
Enanta Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Enanta Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Enanta Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Enanta financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Enanta Pharmaceuticals Stock history
Enanta Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Enanta is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Enanta Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Enanta Pharmaceuticals stock prices may prove useful in developing a viable investing in Enanta Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 21.2 M | 18.4 M | |
| Net Loss | -109.6 M | -104.1 M |
Enanta Pharmaceuticals Quarterly Net Working Capital |
|
Enanta Pharmaceuticals Stock Technical Analysis
Enanta Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Enanta Pharmaceuticals Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Enanta Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Enanta Pharmaceuticals November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Enanta Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Enanta Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Enanta Pharmaceuticals stock market strength indicators, traders can identify Enanta Pharmaceuticals entry and exit signals to maximize returns
Enanta Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Enanta Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Enanta Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Enanta to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.17) | |||
| Jensen Alpha | (0.68) | |||
| Total Risk Alpha | (1.04) | |||
| Treynor Ratio | (1.00) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Enanta Stock analysis
When running Enanta Pharmaceuticals' price analysis, check to measure Enanta Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enanta Pharmaceuticals is operating at the current time. Most of Enanta Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Enanta Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enanta Pharmaceuticals' price. Additionally, you may evaluate how the addition of Enanta Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |